Generic Drugs

NWHN Statement on FDA’s Decision on Generic Drug Labels

By Cindy Pearson | Dec 13, 2018 | Comments Off on NWHN Statement on FDA’s Decision on Generic Drug Labels

FOR IMMEDIATE RELEASE Contact: Evita Almassi, ealmassi@nwhn.org or (202) 682-6240

Generic vs. Brand Name Prescription Drugs

By Ali Tweedt | Jul 13, 2017 | Comments Off on Generic vs. Brand Name Prescription Drugs

What’s the difference between generic and brand-name prescription drugs?

Your Generic Drug Label Doesn’t Tell You EVERYTHING

By Cindy Pearson | Aug 13, 2015 | Comments Off on Your Generic Drug Label Doesn’t Tell You EVERYTHING

Last week we attended a public meeting at the Food and Drug Administration (FDA) where we testified in front of supporters and opponents on behalf of the FDA’s proposed rule on Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products.

Generic Drugs

By NWHN Staff | Aug 13, 2015 | Comments Off on Generic Drugs

More than 80 percent of prescriptions filled in the United States are for generic drugs. Women get these prescriptions with the assumption that the drugs they’ve been prescribed are safe and effective.

FDA Meeting – Generic Drug Labeling

By Coco Jervis | Mar 27, 2015 | Comments Off on FDA Meeting – Generic Drug Labeling

Statement of Coco Jervis, J.D., Program Director |
Food and Drug Administration Public Meeting on Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products

National Women’s Health Network Supports Parity in Generic Drug Labeling

By Coco Jervis | Mar 27, 2015 | Comments Off on National Women’s Health Network Supports Parity in Generic Drug Labeling

FOR IMMEDIATE RELEASE
Contact:  Coco Jervis 202.407.0788

Rx for Change: Sorry, We’re Out of Aspirin…

By Charlea T. Massion, MD, and Adriane Fugh-Berman, MD | May 1, 2012 | Comments Off on Rx for Change: Sorry, We’re Out of Aspirin…

What’s behind the shortage of common generic medications? The number of reported prescription drug shortages in the United States nearly tripled between 2005 and 2010. At the same time that new and expensive drugs are dominating the market, proven workhorse drugs with a long history of successful use — like the two your doctor tried to order for you  — are becoming harder to obtain.